Dhirendra Nath Barman

Dr. Dhirendra Nath Barman


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2024 in Egyptian Journal of Medical Human Genetics
Verified
Journal Article
Open access
PDF file
FMFarhana Siddiqi Mitu
Farhana Siddiqi Mitu
MHMurad Hossain
Murad Hossain
SDShuvo Chandra Das
Shuvo Chandra Das
MIMafizul Islam
Mafizul Islam
DBDhirendra Nath Barman
Dhirendra Nath Barman
SGShipan Das Gupta
Shipan Das Gupta
Background: Type 2 diabetes mellitus (T2DM) is considered to be a polygenic disorder that emerges as a result of complicated gene-environment interactions. Several investigations revealed that SLC30A8 rs13266634 polymorphism elevates T2DM risk. T2DM and hypertension (HTN) are often found to be coexist. Compared to normotensive non-diabetic controls, T2DM patients with HTN have a fourfold increased risk of cardiovascular disease (CVD). The average age of T2DM diagnosis is decreasing, and ‘early onset of T2DM’ in adolescents and young adults is an emerging worldwide health concern. The objective of this study was to examine the potential correlations of SLC30A8 rs13266634 polymorphism with T2DM and T2DM-related CVD and HTN as well as ‘early onset of T2DM’ in the Noakhali region. Methods: This case–control study involved 163 T2DM patients and 75 healthy controls for analysis of SLC30A8-rs13266634 polymorphism. Genotyping of this polymorphism was performed using polymerase chain reaction-restriction fragment length polymorphism (PCR–RFLP) method. MedCalc and Gene Calc programs were used for statistical analysis. Results: A statistically significant association of SLC30A8 rs13266634 (P < 0.05) with T2DM was found in dominant, over dominant and allele models. But this study found no evidence of a connection between SLC30A8-rs13266634 with CVD, HTN, or ‘early onset of T2DM’ in any models. Furthermore, T2DM patients had higher total cholesterol (TC) and triglyceride (TG) levels than non-diabetics individuals. Conclusions: This study revealed a substantial association between the variation in SLC30A8-rs13266634 and the increased risk of developing T2DM within a sample of the Noakhali population in Bangladesh. However, no significant associations were observed between SLC30A8-rs13266634 and T2DM-related cardiovascular disease (CVD), hypertension (HTN), or the early onset of T2DM within this specific population.

23 November 2023 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
PDF file
VCVivian Chakma
Vivian Chakma
DBDhirendra Nath Barman
Dhirendra Nath Barman
SDShuvo Chandra Das
Shuvo Chandra Das
AHAnwar Hossain
Anwar Hossain
MMMonira Binte Momin
Monira Binte Momin
SGShipan Das Gupta
Shipan Das Gupta
Staphylococcus aureus is a gram-positive spherical bacteria and the most common cause of nosocomial infections in the world. Given its clinical significance, the genome sequence of S. aureus has been elucidated to enhance our comprehension of its lifestyle and pathogenicity. The research aimed to summarize a potential hypothetical protein that may play an important role in S. aureus virulence and pathogenicity, covering its anticipated structure, probable biological functions, and importance in this context. A hypothetical protein, YP_498675.1 with 281 amino acid residues of S. aureus, was chosen for analysis and modeling by several bioinformatics tools and databases in this work. According to primary and secondary structure analyses, YP_498675.1 is a stable hydrophilic protein with a significant proportion of α–helices. Subcellular localization predictions by CELLO, PSORTb, and SOSUI server indicate that it is a cytoplasmic protein. NCBI-CDD, Pfam, and InterProScan functional genomics research revealed that the hypothetical protein may include the pyridoxal phosphate (PLP)-dependent 2, 3-diaminopropionate biosynthesis protein SbnA domain. In the homology modeling method, the HHpred server was employed to create its 3D structure using the template structure of a Staphyloferrin B precursor biosynthetic enzyme SbnA bound to PLP (PDB ID: 5D84_A), an X-ray diffraction model having 100% sequence identity with the hypothetical protein. After energy minimization, several quality assessments and validation factors determined that the generated protein model was reliable and of reasonable quality. The present study has characterized and functionally annotated the hypothetical protein YP_498675.1 of S. aureus. Further experimental validation would aid in determining the actual function of YP_498675.1 as well as confirm the protein’s value as a therapeutic target.

6 February 2025 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
MHMithu Howlader
Mithu Howlader
SDShuvo Chandra Das
Shuvo Chandra Das
SGShipan Das Gupta
Shipan Das Gupta
DBDhirendra Nath Barman
Dhirendra Nath Barman
MIMohammed Mafizul Islam
Mohammed Mafizul Islam
MHMurad Hossain
Murad Hossain

30 September 2023 in Genomics & Informatics
Verified
Journal Article
Open access
PDF file
MSMunia Sultana
Munia Sultana
MIMafizul Islam
Mafizul Islam
MHMurad Hossain
Murad Hossain
ARAnisur Rahman
Anisur Rahman
SDShuvo Chandra Das
Shuvo Chandra Das
SGShipan Das Gupta
Shipan Das Gupta
Type 2 diabetes mellitus (T2DM) is a multifactorial, polygenic, and metabolically complicated disease. A large number of genes are responsible for the biogenesis of T2DM and calpain10 (CAPN10) is one of them. The association of numerous CAPN10 genetic polymorphisms in the development of T2DM has been widely studied in different populations and noticed inconclusive results. The present study is an attempt to evaluate the plausible association of CAPN10 polymorphism SNP-19 (rs3842570) with T2DM and T2DM-related anthropometric and metabolic traits in the Noakhali region of Bangladesh. This case-control study included 202 T2DM patients and 75 healthy individuals from different places in Noakhali. A significant association (p < 0.05) of SNP-19 with T2DM in co-dominant 2R/3R vs. 3R/3R (odds ratio [OR], 2.7; p=0.0014) and dominant (2R/3R) + (2R/2R) vs. 3R/3R (OR, 2.47; p=0.0011) genetic models was observed. High-risk allele 2R also showed a significant association with T2DM in the allelic model (OR, 1.67; p=0.0109). The genotypic frequency of SNP-19 variants showed consistency with Hardy-Weinberg Equilibrium (p > 0.05). Additionally, SNP-19 genetic variants showed potential associations with the anthropometric and metabolic traits of T2DM patients in terms of body mass index, systolic blood pressure, diastolic blood pressure, total cholesterol, and triglycerides. Our approach identifies the 2R/3R genotype of SNP-19 as a significant risk factor for biogenesis of T2DM in the Noakhali population. Furthermore, a large-scale study could be instrumental to correlate this finding in overall Bangladeshi population.

23 June 2025 in Journal of Genetic Engineering and Biotechnology
Verified
Journal Article
Open access
NINur Islam
Nur Islam
IAIsrat Jahan Asha
Israt Jahan Asha
AGAninda Kumar Gain
Aninda Kumar Gain
RIRaihanul Islam
Raihanul Islam
SGShipan Das Gupta
Shipan Das Gupta
DBDhirendra Nath Barman
Dhirendra Nath Barman
Dengue is a viral disease caused by Aedes aegypti and Aedes albopictus mosquitoes, leads to severe health complications, including dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). The disease has intensified in Asian countries such as Bangladesh, India, Myanmar, and Thailand, with regular outbreaks since 2015, partly due to the lack of effective vaccines or treatments against this ferocious virus. Nonstructural (NS) genes of Dengue virus (DENV) are believed to play vital role in viral replication. Targeting the NS genes of existing serotypes of DENV, we aimed to design a potential small interfering RNA (siRNA) that has the capability to silence the NS genes hence, provide a ground strategy for antiviral therapeutics. In this investigation, a comprehensive computational approach encompassing data collection from NCBI database, GC content analysis, conservation prediction across all DENV serotypes, mRNA-siRNA duplex thermodynamic assessment, siRNA efficacy evaluation, molecular modeling and structural refinement, molecular docking were performed. These analyses anticipated three efficient siRNAs (S2, S3 and S11) that could have the capability to silence all the NS protein-coding genes employed by the DENV. Based on additional analysis including molecular dynamic (MD) simulation, principal component analysis (PCA) and free energy landscape (FEL), two siRNAs (S2 and S11) were recommended as potential therapeutics that could effectively degrade viral NS protein-coding genes through the RNAi pathway. However, S2 (Guide: 5'-UGUUUUUCGCCUUUUUCCGUU-3' and Passenger: 5'- CGGAAAAAGGCGAAAAACACG-3') molecule is supposed to be appeared the most promising siRNA compared to S11. This study is the foundational contribution enabling chemically synthesized future antiviral drug discovery for combating DENV, especially in the Asian region where frequent outbreaks are common. Nonetheless, in vivo validation and further evaluations are necessary before these siRNAs can be advanced as molecular therapeutics.

1 January 2024 in Evolutionary Bioinformatics
Verified
Journal Article
Open access
IAIsrat Jahan Asha
Israt Jahan Asha
SGShipan Das Gupta
Shipan Das Gupta
MHMurad Hossain
Murad Hossain
NINur Islam
Nur Islam
NANurun Nahar Akter
Nurun Nahar Akter
DBDhirendra Nath Barman
Dhirendra Nath Barman
Objective: Neisseria meningitidis is an encapsulated, diplococcus, kidney bean-shaped bacteria that causes bacterial meningitis. Our study hopes to advance our understanding of disease progression, the spread frequency of the bacteria in people, and the interactions between the bacteria and human body by identifying a functional protein, potentially serving as a target for meningococcal medicine in the future. Methods: A hypothetical protein HP (PBJ89160.1) from N. meningitidis was employed in this study for extensive structural and functional characterization. In the predictive functional role of HP, several constitutive bioinformatics approaches are applied, such as prediction of physiological properties, domain and motif family function, secondary and tertiary structure prediction, energy minimization, quality validation, docking, and ADMET analysis. To create the protein’s three-dimensional (3D) structure, a template protein (PDB_ID: 3GXA) is used with 99% sequence identity by homology modeling technique with the HHpred server. To mitigate the pathogenicity associated with the HP function, it was docked with the natural ligand methionine and five other drug compounds like Verapamil, Loperamide, Thioridazine, Chlorpromazine, and Auranofine. Results: The protein is predicted to be acidic, soluble and hydrophilic by physicochemical properties analysis. Subcellular localization analysis demonstrated the protein to be periplasmic. The HP has an ATP-binding cassette transporter (also known as ABC transporter) involved in uptake of methionine (MetQ) that creates nutritional virulence in host. Energy minimization, multiple quality assessments, and validation value determination led to the conclusion that the HP model had a workable and acceptable quality. Following ADMET analysis and binding affinity assessments from the docking studies, Loperamide emerged as the most promising therapeutic compound, effectively inhibiting the ATP transporter activity of the HP. Conclusion: Comparative genomic analysis revealed that this protein is specific to N. meningitidis and has no homologs in human proteins, thereby identifying it as a potential target for therapeutic intervention.